News
Pharmaceutical firm Pfizer is expected to make an announcement on ...
18 May 2010
The pharmaceutical company completed a $67 billion purchase of Wyeth in October. Last year, Pfizer confirmed it would cut 19000 jobs, about 15 per cent of ...
Click on the link to read the full article at Irish Times (This link will open in a new window)Parexel rides China wave with two new offices
18 May 2010
The rush to China continues, both among pharmaceutical companies and the contract research organisations (CROs) that service their outsourcing needs. ...
Click on the link to read the full article at Pharma Times (This link will open in a new window)Otsuka Pharmaceutical Co Ltd in OTC Healthcare - Company Profile - new market ...
18 May 2010
This Otsuka Pharmaceutical Co Ltd in OTC HealthCare company profile offers detailed strategic analysis of the company´s business, examining its performance ...
Click on the link to read the full article at PR-inside.com (press release) (This link will open in a new window)Luna Innovations Leads the Companies in the Biotechnology Industry Offering ...
18 May 2010
Below are the top five companies in the Biotechnology industry as measured by the price to sales per share ratio. Often companies with the ...
Click on the link to read the full article at Comtex Smartrend (This link will open in a new window)Experts Worry Over Slow Biotechnology Regulation In Uganda
18 May 2010
The Draft Biotechnology and Biosafety Bill is yet to be tabled before the Uganda cabinet and parliament. The challenges surrounding regulatory frameworks ...
Click on the link to read the full article at Africa Science News Service (This link will open in a new window)Legislative Yuan speaker backs Taipei biotech park
18 May 2010
Yesterday, Wang spoke of the issue during a speech at a forum held by pharmaceutical manufacturers, for whom advances in biotechnology is of upmost ...
Click on the link to read the full article at China Post (This link will open in a new window)The price is wrong
18 May 2010
Generics will then keep entering until the price is driven down to a level close to costs. Ontario tried doing this, but only at the price levels of 70% ...
Click on the link to read the full article at Financial Post (This link will open in a new window)Pharma industry enters critical phase as patent cliff looms large, hastening ...
18 May 2010
The findings, based on a survey of 381 executives across the pharmaceutical and biotechnology sectors, shows that big pharma is becoming increasingly ...
Click on the link to read the full article at Cambridge Network (This link will open in a new window)Emergent BioSolutions, Inc., named biotechnology firm of the year
17 May 2010
Emergent BioSolutions, Inc., was honored as the Biotechnology Firm of the Year by the Tech Council of Maryland at its ...
Click on the link to read the full article at BioPrepWatch.com (This link will open in a new window)Impax receives tentative approval for generic Opana ER
17 May 2010
The drug is a generic version of Endo Pharmaceuticals' Opana ER, which had sales of $241 million during the 12-month period ended in March, according to ...
Click on the link to read the full article at Drug Store News (This link will open in a new window)
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
